While market sentiment remains buoyant, fresh data from Teradata underscores a sobering reality for the technology sector. According to a new report, 68% of global enterprises are still confined to the early stages of AI development. Only 7% of firms have successfully reached a maturity level capable of producing tangible results, a statistic highlighting the friction between hype and implementation.

Teradata CIO Josh Fecteau is scheduled to join the NYSE floor today to dissect these findings alongside broader industry trends. The conversation arrives as the MACHINA Summit begins its focus on physical AI, with the upcoming RAISE Summit in Paris set to further track the pulse of global innovation. Meanwhile, in the pharmaceutical sector, Annovis Bio has reached a critical milestone, confirming the full enrollment of 850 patients for the Phase 3 trial of its Alzheimer's treatment, Buntanetap.